Gender specific short stature in male adolescents with obsessive-compulsive disorder

Journal of Obsessive-Compulsive and Related Disorders

Volumn 2, Issue 1, 2013, Pages 30-36

  Hu, Yu Pei ^a   Wehrly, Rebecca ^c   Gorrindo, Tristan ^b   Hezel, Dianne M ^b   Gironda, Christina ^a   Jenike, Michael A ^a,c   Evelyn Stewart, S ^a,d,e  

^a MCLEAN HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e British Columbia Mental Health and Addictions Research Institute   (Canada)

Author keywords

Adolescent; Gender; Growth; Height; Obsessive compulsive disorder; Serotonin reuptake inhibitor; Short stature

Indexed keywords

AMPHETAMINE; ARIPIPRAZOLE; CITALOPRAM; CLOMIPRAMINE; DESMETHYLPHENIDATE; DEXAMPHETAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; METHYLPHENIDATE; QUETIAPINE; RISPERIDONE; SERTRALINE; TRAZODONE; UNCLASSIFIED DRUG; VENLAFAXINE;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; DSM-IV; FEMALE; GENDER; GILLES DE LA TOURETTE SYNDROME; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SEX DIFFERENCE; SHORT STATURE;

EID: 84870506020     PISSN: 22113649     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocrd.2012.07.009     Document Type: Article

References (52)

1. Altman S.E., Shankman S.A. What is the association between obsessive-compulsive disorder and eating disorders?. Clinical Psychology Review 2009, 29(7):638-646.
2. American Psychiatric Association Diagnostic criteria from D. S. M.-IV-TR 2000, American Psychiatric Association, Washington, D.C.
3. Barr L.C., Goodman W.K., Price L.H., McDougle C.J., Charney D.S. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. Journal of Clinical Psychiatry 1992, 53(Suppl. 17-28).
4. Biederman J., Faraone S.V., Monuteaux M.C., Plunkett E.A., Gifford J., Spencer T. Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment. Pediatrics 2003, 111(5 Pt 1):1010-1016.
5. Bienvenu O.J., Samuels J.F., Riddle M.A., et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biological Psychiatry 2000, 48(4):287-293.
6. Brambilla F., Bellodi L., Perna G., Arancio C., Bertani A. Growth hormone response to growth hormone-releasing hormone stimulation in obsessive-compulsive disorder. Psychiatry Research 1998, 81(3):293-299.
7. Cara J.F. Growth hormone in adolescence. Normal and abnormal. Endocrinology and Metabolism Clinics of North America 1993, 22(3):533-552.
8. Castle D.J., Deale A., Marks I.M. Gender differences in obsessive compulsive disorder. Australian and New Zealand Journal of Psychiatry 1995, 29(1):114-117.
9. Denys D., Zohar J., Westenberg H.G. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. Journal of Clinical Psychiatry 2004, 65(Suppl 14):11-17.
10. Dickel D.E., Veenstra-VanderWeele J., Cox N.J., et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Archives of General Psychiatry 2006, 63(7):778-785.
11. Douglass H.M., Moffitt T.E., Dar R., McGee R., Silva P. Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. Journal of the American Academy of Child & Adolescent Psychiatry 1995, 34(11):1424-1431.
12. Drieling T., Biedermann N.C., Schärer L.O., Strobl N., Langosch J.M. [Psychotropic drug-induced change of weight: a review]. Fortschritte der Neurologie-Psychiatrie 2007, 75(2):65-80.
13. Eichstedt J.A., Arnold S.L. Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD?. Clinical Psychology Review 2001, 21(1):137-157.
14. Faraone S.V., Biederman J., Morley C.P., Spencer T.J. Effect of stimulants on height and weight: a review of the literature. Journal of the American Academy of Child & Adolescent Psychiatry 2008, 47(9):994-1009.
15. Flament M.F., Whitaker A., Rapoport J.L., et al. Obsessive compulsive disorder in adolescence: an epidemiological study. Journal of the American Academy of Child & Adolescent Psychiatry 1988, 27(6):764-771.
16. Hamburger S.D., Swedo S., Whitaker A., Davies M., Rapoport J.L. Growth rate in adolescents with obsessive-compulsive disorder. American Journal of Psychiatry 1989, 146(5):652-655.
17. Henninghausen K., Rischmüller B., Heseker H., Remschmidt H., Hebebrand J. Low body mass indices in adolescents with obsessive-compulsive disorder. Acta Psychiatrica Scandinavica 1999, 99(4):267-273.
18. Katz N., Gothelf D., Hermesh H., Weizman A., Apter A., Horev G. Bone age in adolescents with schizophrenia and obsessive-compulsive disorder. Schizophrenia Research 1998, 33(1-2):119-122.
19. Kessler R.C., Demler O., Frank R.G., et al. Prevalence and treatment of mental disorders, 1990 to 2003. New England Journal of Medicine 2005, 352(24):2515-2523.
20. Keys A., Fidanza F., Karvonen M.J., Kimura N., Taylor H.L. Indices of relative weight and obesity. Journal of Chronic Diseases 1972, 25(6):329-343.
21. Klein R.G., Mannuzza S. Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height. Archives of General Psychiatry 1988, 45(12):1131-1134.
22. Kliegman R. Nelson essentials of pediatrics 2006, Elsevier Saunders, Philadelphia, PA. 5th ed.
23. Kluge M., Schüssler P., Weikel J., et al. Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorder. Psychoneuroendocrinology 2006, 31(9):1098-1104.
24. Kurlan R. Clinical practice. Tourette's Syndrome. New England Journal of Medicine 2010, 363(24):2332-2338.
25. Labad J., Menchon J.M., Alonso P., et al. Gender differences in obsessive-compulsive symptom dimensions. Depression and Anxiety 2008, 25(10):832-838.
26. Lanktree M.B., Guo Y., Murtaza M., et al. Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height. American Journal of Human Genetics 2011, 88(1):6-18.
27. Lensi P., Cassano G.B., Correddu G., Ravagli S., Kunovac J.L., Akiskal H.S. Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences. British Journal of Psychiatry 1996, 169(1):101-107.
28. Lifshitz F. Pediatric endocrinology 2007, Informa Healthcare, New York. 5th ed.
29. Lochner C., Hemmings S.M., Kinnear C.J., et al. Gender in obsessive-compulsive disorder: clinical and genetic findings. European Neuropsychopharmacology 2004, 14(2):105-113.
30. MacMaster F.P., Russell A., Mirza Y., et al. Pituitary volume in pediatric obsessive-compulsive disorder. Biological Psychiatry 2006, 59(3):252-257.
31. Masi G., Millepiedi S., Perugi G., et al. A naturalistic exploratory study of the impact of demographic, phenotypic and comorbid features in pediatric obsessive-compulsive disorder. Psychopathology 2010, 43(2):69-78.
32. Norušis M.J., S.P.S.S.Inc. The SPSS guide to data analysis for SPSS/PC+ 1991, SPSS, Chicago, IL. 2nd ed.
33. Ogden C.L., Fryar C.D., Carroll M.D., Flegal K.M. Mean body weight, height, and body mass index, United States 1960-2002. Advance Data 2004, 347:1-17.
34. Ogden C.L., Kuczmarski R.J., Flegal K.M., et al. Centers for disease control and prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002, 109(1):45-60.
35. Pauls D.L., Leckman J.F. The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. New England Journal of Medicine 1986, 315(16):993-997.
36. Perola M., Sammalisto S., Hiekkalinna T., et al. Combined genome scans for body stature in 6,602 European twins: evidence for common Caucasian loci. PLoS. Genetics 2007, 3(6):e97.
37. Pine D.S., Cohen P., Brook J. Emotional problems during youth as predictors of stature during early adulthood: results from a prospective epidemiologic study. Pediatrics 1996, 97(6 Pt 1):856-863.
38. Poulton A. Growth on stimulant medication; clarifying the confusion: a review. Archives of Disease in Childhood 2005, 90(8):801-806.
39. Rasmussen S.A., Eisen J.L. Clinical and epidemiologic findings of significance to neuropharmacologic trials in OCD. Psychopharmacol Bulletin 1988, 24(3):466-470.
40. Rasmussen S.A., Eisen J.L. Epidemiology of obsessive compulsive disorder. Journal of Clinical Psychiatry 1990, 51(Suppl:10-13). discussion 14.
41. Robertson M.M. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. Journal of Psychosomatic Research 2008, 65(5):461-472.
42. Rotge J.Y., Aouizerate B., Tignol J., Bioulac B., Burbaud P., Guehl D. The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms. Neuroscience 2010, 165(2):408-417.
43. Rubenstein C.S., Pigott T.A., L'Heureux F., Hill J.L., Murphy D.L. A preliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive compulsive disorder. Journal of Clinical Psychiatry 1992, 53(9):309-314.
44. Sheppard B., Chavira D., Azzam A., et al. ADHD prevalence and association with hoarding behaviors in childhood-onset OCD. Depress Anxiety 2010, 27(7):667-674.
45. Silventoinen K., Sammalisto S., Perola M., et al. Heritability of adult body height: a comparative study of twin cohorts in eight countries. Twin Research and Human Genetics 2003, 6(5):399-408.
46. Spencer T.J., Biederman J., Harding M., O'Donnell D., Faraone S.V., Wilens T.E. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?. Journal of the American Academy of Child & Adolescent Psychiatry 1996, 35(11):1460-1469.
47. Stewart S.E., Pauls D.L. The genetics of obsessive-compulsive disorder. Focus 2010, 8(3):350-357.
48. Stewart S.E., Yen C.H., Stack D.E., Jenike M.A. Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment. Journal of Psychiatry Research 2006, 40(6):511-519.
49. Uhde T.W., Tancer M.E., Rubinow D.R., et al. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers. Neuropsychopharmacology 1992, 6(2):101-118.
50. Weintrob N., Cohen D., Klipper-Aurbach Y., Zadik Z., Dickerman Z. Decreased growth during therapy with selective serotonin reuptake inhibitors. Archives of Pediatrics & Adolescent Medicine 2002, 156(7):696-701.
51. Zelnik N., Newfield R.S., Silman-Stolar Z., Goikhman I. Height distribution in children with Tourette syndrome. Journal of Child Neurology 2002, 17(3):200-204.
52. Zohar J., Kennedy J.L., Hollander E., Koran L.M. Serotonin-1D hypothesis of obsessive-compulsive disorder: an update. Journal of Clinical Psychiatry 2004, 65(Suppl 14):18-21.